IRCT201601031556N84已完成未知
Carnosine added to ritaline in the treatment of ADHD: A double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 17 years（—）
- 性别
- All
入选标准
- •diagnosis of ADHD based on DSM-5; age between 6-17 years old.
- •Exclusion criteria: mental retardation; receiving of L carnosine during the last 3 weeks; presence of any psychiatric disorders except for ODD; history of allergy to L carnosine or Ritaline; presence of any medical problem including cardiovascular diseases; presence of uncontrolled seizures; systolic blood pressure more than 120 mm Hg; resting pulse rate less than 60/minute or more than 115/minute; receiving any supplement or medication for ADHD.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50
已完成
不适用
Carnosine in the treatment of OCDObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201604201556N88Tehran University of Medical Sciences50
已完成
3 期
carnosine in SchizophreniaCTRI/2019/02/017646Brio Bliss life science pvtltd100
招募中
2 期
carnosine in treatment of major depressive disorderIRCT20170123032145N2Iran University of Medical Sciences50
已完成
3 期
carnosine in patients with schizophreniaschizophrenia.schizophreniaIRCT201504211556N75Tehran University of Medical Sciences50